Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-03 · accession 0001209191-21-068291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-07 | 2021-12-03 | ABCL | Lo Andrew | Dir | P - Purchase | $14.02 | +86.9K | 86.9K | New | +$1.22M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Share Option (right to buy) | 2021-12-03 | P | A | 86,938 | $14.02 | 86,938 | D | — | — |